Medical expert of the article
New publications
American gays will be vaccinated against cervical cancer
Last reviewed: 23.04.2024
All iLive content is medically reviewed or fact checked to ensure as much factual accuracy as possible.
We have strict sourcing guidelines and only link to reputable media sites, academic research institutions and, whenever possible, medically peer reviewed studies. Note that the numbers in parentheses ([1], [2], etc.) are clickable links to these studies.
If you feel that any of our content is inaccurate, out-of-date, or otherwise questionable, please select it and press Ctrl + Enter.
The US Food and Drug Administration (FDA) has authorized the use of the papillomavirus vaccine for the prevention of anterior cancers, the incidence of which is increasing among homosexual men, MSNBC reports.
The vaccine against papillomaviruses 6, 11, 16 and 18 types, produced by Merck & Co under the name Gardasil (Gardasil), has been widely used in Western countries since 2006 to prevent cervical, vulvar and vaginal cancer (up to 70 percent of these tumors are caused by these types of the virus).
In addition to these types of cancer, papillomaviruses are associated with most cases of penile cancer and anus. According to clinical trials on homosexual men given to the FDA by Merck & Co., Gardasil can prevent up to 78 percent of anal cancer.
According to the National Cancer Institute of the United States, the cancer of the anus is developing in about 1.6 people per 100,000 inhabitants, which corresponds to almost 5.3 thousand cases per year. About 720 patients a year die. The incidence of this type of cancer is growing rapidly among homosexuals - currently it is 40 cases per 100 thousand representatives of this contingent per year. Although in general, women are ill more often.
Given these findings, the FDA approved the use of the vaccine for the prevention of anterior cancers in later life in women and men aged 9 to 26 years. In the absence of contraindications, she can be vaccinated for everyone.
[